Transurethral injection of polyacrylamide hydrogel (Bulkamid(R)) for the treatment of female stress urinary incontinence and changes in the cure rate over time
Abstract
A retrospective study was performed on 52 women with urinary incontinence (stress, 43; mixed 9). One patient died during study.
Forty patients had previously undergone anti-incontinence surgery. The efficacy of TUI was evaluated 3 months (± 1 week) and an average of 22 months after surgery.
Subjective assessment of the leakage of urine was based on the International Consultation on Incontinence Questionnaire – Short form (ICIQ-UI SF) filled in before, three and – on average – 22 months after the surgery (minimum time after surgery was 6 months). Improvement in urinary incontinence was defined as a drop in the score of more than 50%.
Objective assessment of leakage of urine was assessed by cough test. The cure effect was evaluated by VAS (Visual Analogue Scale) score and by using the five-point Likert score.
Ethical committee approval was obtained, and all subjects gave written informed consent to participate in the study.